KATHERINE BLACKWELL: Open Payments
NPI 1942570973 · PORT HURON, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$921 in 51 payments from 14 companies in 2025. Trend: 2023 $538 · 2024 $821 · 2025 $921
Food & beverage: $921
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 13 | $217 |
| ABBVIE INC. | 10 | $150 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $91 |
| Radius Health, Inc. | 4 | $82 |
| Novo Nordisk Inc | 3 | $59 |
| Amgen Inc. | 3 | $56 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $52 |
| PFIZER INC. | 2 | $45 |
| Lundbeck LLC | 2 | $43 |
| GlaxoSmithKline, LLC. | 2 | $32 |
Products named: REXULTI, CAPLYTA, VRAYLAR, Tymlos, QULIPTA, XIFAXAN, NURTEC ODT, Wegovy.
Industry payments across MI — which companies pay providers there.
